ELOVL5 and breast carcinoma: Furthermore, this study proves to be very interesting from a clinical perspective by suggesting a predictive potential of Elovl5 expression as prognosis marker in the risk of development of metastases in patients with breast cancer and by describing a therapeutic potential for drugs preventing the formation of lipid droplets in cancer cells.